Computational nanochemistry report on the oxicams--conceptual DFT indices and chemical reactivity.
Martínez-Araya JI, Salgado-Morán G, Glossman-Mitnik D.
J Phys Chem B · research support, non-u.s. gov't; journal article · DOI 10.1021/jp400241q PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för droxicam. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
24 hitsElectrochemical behaviour of droxicam: kinetic study in aqueous-organic media.
Acuña JA, de la Fuente C, Vázquez MD, Tascón ML, Gómez MI, Mata F, Sánchez-Batanero P.
J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/s0731-7085(02)00041-9[Chronic autoimmune hepatitis following cholestatic hepatitis caused by droxicam].
Pérez-Aguilar F, Berenguer M, Ramírez-Palanca JJ, Payà A, Vera-Sempere FJ, Sánchez-Cuenca JM, Berenguer J.
Med Clin (Barc) · journal article; case reports[Droxicam-induced toxic hepatitis].
Berenguer M, Pérez-Aguilar F, Gisbert C, Ferreres LA, Vera-Sempere FJ, Berenguer J.
Rev Esp Enferm Dig · journal article; case reportsA comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya MT, Pais JP, Ruas Da Silva J, Morais JA.
Eur J Drug Metab Pharmacokinet · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/bf03190244[Hepatotoxicity induced by Droxicam: presentation of 4 cases].
Morillas Ariño J, Sánchez de la Fuente MF, García-Cano Lizcano J, Jiménez Sánchez F, Rosa Herranz C, Razquin Murillo J, Pérez Sola A, González Martín JA.
Rev Esp Enferm Dig · journal article; case reports[Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam].
Chevallard M, Venegoni C, Colombo B.
Minerva Med · comparative study; clinical trial; randomized controlled trial; journal articleThe effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J.
J Clin Pharmacol · comparative study; journal article · DOI 10.1177/009127009203201210[Toxic hepatitis caused by droxicam].
Cancelo Suárez P, Prieto de Paula JM, de la Cueva Gallo JA, Velasco Osés A.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
Caballería Rovira E, Aragó López JV, Massó Ubeda RM, Sanchís Closa A.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
Rosselló T, Fiol F.
Med Clin (Barc) · letter; comment; case reports[Toxic hepatitis caused by droxicam].
López-Tierra G, Merino MJ, Gómez-Camacho E, Ollero M.
Med Clin (Barc) · letter; case reportsPharmacokinetic profile of droxicam.
Martínez L, Sánchez J.
Eur J Rheumatol Inflamm · review; journal articleTherapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
Schüetz E, Sánchez J, García-Barbal J, Sarti JF, Reuter C, Harrison FJ.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleDouble-blind, randomized and parallel comparison between droxicam and diclofenac sodium in patients with coxarthrosis and gonarthrosis.
Corts Giner JR, García Borrás JJ.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleComparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis.
Rodríguez-de-la-Serna A, Geli-Ferrer C, Diaz-López C, Sánchez-García J.
Eur J Rheumatol Inflamm · comparative study; clinical trial; randomized controlled trial; journal articleA pharmacokinetic study to evaluate the profile of droxicam in elderly healthy volunteers after a single oral dose of 20mg.
Hosie J, Kelly J, Sánchez J, Bartlett A, Harrison FJ.
Eur J Rheumatol Inflamm · clinical trial; journal articleAdverse events with droxicam in the early clinical trials.
Sánchez J, Bartlett A, Costa A, Estruch J, Estiarte R, Soucheiron C.
Eur J Rheumatol Inflamm · journal articleThe influence of gastric emptying on droxicam pharmacokinetics.
Sánchez J, Martínez L, García-Barbal J, Roser R, Bartlett A, Sagarra R.
J Clin Pharmacol · journal article · DOI 10.1002/j.1552-4604.1989.tb03409.xComparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
Martínez L, Sánchez J, Roser R, García-Barbal J, Bartlett A, Estruch J, Sagarra R, Puig S, Costa A.
Methods Find Exp Clin Pharmacol · comparative study; clinical trial; randomized controlled trial; journal articlePharmacological profile of droxicam.
Esteve J, Farré AJ, Roser R.
Gen Pharmacol · review; journal article · DOI 10.1016/0306-3623(88)90004-3Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.
Esteve J, Martínez L, Roser R, Sagarra R.
Methods Find Exp Clin Pharmacol · journal articlePharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.
Farré AJ, Colombo M, Fort M, Gutiérrez B, Rodríguez L, Roser R.
Methods Find Exp Clin Pharmacol · journal articlePharmacokinetics of droxicam in rat and dog.
Esteve A, Martínez L, Roser R, Sagarra R.
Methods Find Exp Clin Pharmacol · comparative study; journal article